An orally bioavailable broad-spectrum Hsp90 inhibitor (Hsp90i) therapy to suppress emerging Coronavirus (CoV) infections

Research Grant

Duke Scholars

Investigator Timothy Arthur James Haystead Pharmacology & Cancer Biology

Research Scientist Philip Hughes

Awarded By

Good Ventures Foundation

Start Date

May 1, 2020

End Date

June 30, 2021

Awarded By

Good Ventures Foundation

Start Date

May 1, 2020

End Date

June 30, 2021